Interactions of β-Lactamases with Sanfetrinem (GV 104326) Compared to Those with Imipenem and with Oral β-Lactams [PDF]
, 1998 Gioia S. Babini +2 more
openalex +1 more source
Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study [PDF]
, 2005 José Miguel Cisneros +8 more
openalex +1 more source
In vitro efficacy of sulbactam/durlobactam combined with β-lactam antibiotics in Australian Mycobacterium abscessus isolates. [PDF]
J Antimicrob ChemotherPatterson-Fahy K +5 more
europepmc +1 more source
Assessment of Biofilm Formation and Resistance to Imipenem and Ciprofloxacin among Clinical isolates of Acinetobacter baumannii in Tehran [PDF]
, 2014 Ahya Abdi Ali +3 more
openalex +1 more source
Genetic Determinants Linked to MDR/XDR in <i>Pseudomonas aeruginosa</i> Strains from a Mexican Tertiary Hospital. [PDF]
PathogensNicolas-Sayago L +17 more
europepmc +1 more source
Efficacy and safety of imipenem/cilastatin/relebactam (IMI/CS/REL): a meta-analysis of randomized controlled clinical trials [PDF]
Wenjuan Lei +4 more
openalex +1 more source
Pharmacokinetics of imipenem in critically ill patients: Continuous infusion versus extended infusion in a real-world study. [PDF]
J Int Med ResZhang R, Qin Y, Lv Y, Zhang Y.
europepmc +1 more source
From bugs to bots: learning infectious diseases in the AI era. [PDF]
Antimicrob Steward Healthc EpidemiolRodriguez-Nava G.
europepmc +1 more source
Effectiveness of imipenem-relebactam for multidrug-resistant <i>Pseudomonas aeruginosa</i> in pneumonia and bloodstream infections in the United States (MIRAGE). [PDF]
Antimicrob Agents ChemotherWangchinda W +21 more
europepmc +1 more source
In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa [PDF]
, 2019 Katherine Young +13 more
openalex +1 more source